Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|5|6|655-667

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.5, Iss.6, 2005-12, pp. : 655-667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses

By  

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 2015-2023

Bentham Science Publishers

Access to resources Recommend Favorite

Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 113-125

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Virotherapy for Breast Cancer Treatment

By  

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

By Halldén Gunnel   Portella Giuseppe  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 945-958

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers

By  

Current Cancer Drug Targets, Vol. 18, Iss. 2, 2018-01 ,pp. : 188-201

Bentham Science Publishers

Access to resources Recommend Favorite